Latest University of California, San Francisco Stories
UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called “myc,” paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.
Persons who live to an older age are the more likely to be disabled near the end of life and require the assistance of a caregiver to complete the activities of daily living, and disability was more common in women than men two years before death.
Results of a Phase III clinical trial showed that a simple drug regimen of two anti-clotting drugs – clopidogrel and aspirin – lowered the risk of stroke by almost one-third, compared to the standard therapy of aspirin alone, when given to patients who had minor or transient stroke symptoms to prevent subsequent attacks.
A new study by researchers at the Ernest Gallo Clinic and Research Center at UC San Francisco offers encouraging findings that researchers hope may one day lead to a treatment option for people who suffer from alcohol abuse disorders and other addictions.
Memory improved in mice injected with a small, drug-like molecule discovered by UCSF San Francisco researchers studying how cells respond to biological stress.
Diabetes-associated episodes of low blood sugar may increase the risk of developing dementia, while having dementia or even milder forms of cognitive impairment may increase the risk of experiencing low blood sugar.
Women with coronary heart disease could be at risk for elevated levels of inflammation if they aren’t getting enough sleep, according to new research published online Wednesday in the Journal of Psychiatric Research.
- A handkerchief.
- In general, any miraculous portrait of Christ.